Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Distress Tolerance and HIV Prevention With XR-NTX Initiation in Opioid Dependence

NCT02602795 is registered in ClinicalTrials.gov with Rhode Island Hospital as lead sponsor.

NCT NCT02602795
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02602795 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Distress Tolerance and HIV Prevention With XR-NTX Initiation in Opioid Dependence
Lead sponsor
Rhode Island Hospital
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2015
Completion date
June 30, 2018
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, opiate dependence, sexually transmitted diseases